Brain metastases from malignant Brenner tumor of the ovary: A case report and a literature review

Valerio Donato, Cristina Donfrancesco, Carlotta Bracchi, C. Marchetti, M. Schiavi, V. Colagiovanni, M. Monti, G. Bogani, A. Maturo, P. L. Benedetti Panici

Research output: Contribution to journalReview article

Abstract

Introduction: Brenner tumor of the ovary represents an uncommon neoplasm. It constitutes about 1.5% of all ovarian tumors with a peak of incidence in the fifth decade. The vast majority of Brenner tumors is benign, while only 1% is malignant and associated with a poor prognosis. Diagnosis could be made only with histological examination, and surgery is the mainstay of treatment. Materials and methods: Here we present the case of a patient affected by a malignant Brenner tumor of the ovary, with metastases to brain, lung and liver and by a concomitant low grade endometroid adenocarcinoma of the uterus. A postoperative platinum based chemotherapy (CHT) was planned. The adjuvant treatment was discontinued for hematologic and liver toxicity and the patient died one month later due to a cardiorespiratory arrest. Results and discussion: For what concerns adjuvant therapy, it is supposed that chemotherapy is profitable in the survival of these patients, but what agents would really provide an objective response in the presence of metastatic disease is not standardized. Conclusion: Because of the rarity and the limited good quality research reports, multicentric prospective trials are needed to improve preoperative diagnosis of MBTs and investigate the best treatment.

Original languageEnglish
Pages (from-to)339-344
Number of pages6
JournalGiornale Italiano di Ostetricia e Ginecologia
Volume38
Issue number4
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Brenner Tumor
Neoplasm Metastasis
Brain
Drug Therapy
Liver
Proxy
Therapeutics
Platinum
Uterus
Neoplasms
Adenocarcinoma
Lung
Survival
Incidence

Keywords

  • Brenner tumor
  • Metastases
  • Ovarian cancer
  • Ovarian neoplasms

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Brain metastases from malignant Brenner tumor of the ovary : A case report and a literature review. / Donato, Valerio; Donfrancesco, Cristina; Bracchi, Carlotta; Marchetti, C.; Schiavi, M.; Colagiovanni, V.; Monti, M.; Bogani, G.; Maturo, A.; Benedetti Panici, P. L.

In: Giornale Italiano di Ostetricia e Ginecologia, Vol. 38, No. 4, 01.07.2016, p. 339-344.

Research output: Contribution to journalReview article

Donato, Valerio ; Donfrancesco, Cristina ; Bracchi, Carlotta ; Marchetti, C. ; Schiavi, M. ; Colagiovanni, V. ; Monti, M. ; Bogani, G. ; Maturo, A. ; Benedetti Panici, P. L. / Brain metastases from malignant Brenner tumor of the ovary : A case report and a literature review. In: Giornale Italiano di Ostetricia e Ginecologia. 2016 ; Vol. 38, No. 4. pp. 339-344.
@article{2cb0911d6aff480db468d7da60e3bf9c,
title = "Brain metastases from malignant Brenner tumor of the ovary: A case report and a literature review",
abstract = "Introduction: Brenner tumor of the ovary represents an uncommon neoplasm. It constitutes about 1.5{\%} of all ovarian tumors with a peak of incidence in the fifth decade. The vast majority of Brenner tumors is benign, while only 1{\%} is malignant and associated with a poor prognosis. Diagnosis could be made only with histological examination, and surgery is the mainstay of treatment. Materials and methods: Here we present the case of a patient affected by a malignant Brenner tumor of the ovary, with metastases to brain, lung and liver and by a concomitant low grade endometroid adenocarcinoma of the uterus. A postoperative platinum based chemotherapy (CHT) was planned. The adjuvant treatment was discontinued for hematologic and liver toxicity and the patient died one month later due to a cardiorespiratory arrest. Results and discussion: For what concerns adjuvant therapy, it is supposed that chemotherapy is profitable in the survival of these patients, but what agents would really provide an objective response in the presence of metastatic disease is not standardized. Conclusion: Because of the rarity and the limited good quality research reports, multicentric prospective trials are needed to improve preoperative diagnosis of MBTs and investigate the best treatment.",
keywords = "Brenner tumor, Metastases, Ovarian cancer, Ovarian neoplasms",
author = "Valerio Donato and Cristina Donfrancesco and Carlotta Bracchi and C. Marchetti and M. Schiavi and V. Colagiovanni and M. Monti and G. Bogani and A. Maturo and {Benedetti Panici}, {P. L.}",
year = "2016",
month = "7",
day = "1",
doi = "10.11138/giog/2016.38.4.339",
language = "English",
volume = "38",
pages = "339--344",
journal = "Giornale Italiano di Ostetricia e Ginecologia",
issn = "0391-9013",
publisher = "CIC Edizioni Internazionali s.r.l.",
number = "4",

}

TY - JOUR

T1 - Brain metastases from malignant Brenner tumor of the ovary

T2 - A case report and a literature review

AU - Donato, Valerio

AU - Donfrancesco, Cristina

AU - Bracchi, Carlotta

AU - Marchetti, C.

AU - Schiavi, M.

AU - Colagiovanni, V.

AU - Monti, M.

AU - Bogani, G.

AU - Maturo, A.

AU - Benedetti Panici, P. L.

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Introduction: Brenner tumor of the ovary represents an uncommon neoplasm. It constitutes about 1.5% of all ovarian tumors with a peak of incidence in the fifth decade. The vast majority of Brenner tumors is benign, while only 1% is malignant and associated with a poor prognosis. Diagnosis could be made only with histological examination, and surgery is the mainstay of treatment. Materials and methods: Here we present the case of a patient affected by a malignant Brenner tumor of the ovary, with metastases to brain, lung and liver and by a concomitant low grade endometroid adenocarcinoma of the uterus. A postoperative platinum based chemotherapy (CHT) was planned. The adjuvant treatment was discontinued for hematologic and liver toxicity and the patient died one month later due to a cardiorespiratory arrest. Results and discussion: For what concerns adjuvant therapy, it is supposed that chemotherapy is profitable in the survival of these patients, but what agents would really provide an objective response in the presence of metastatic disease is not standardized. Conclusion: Because of the rarity and the limited good quality research reports, multicentric prospective trials are needed to improve preoperative diagnosis of MBTs and investigate the best treatment.

AB - Introduction: Brenner tumor of the ovary represents an uncommon neoplasm. It constitutes about 1.5% of all ovarian tumors with a peak of incidence in the fifth decade. The vast majority of Brenner tumors is benign, while only 1% is malignant and associated with a poor prognosis. Diagnosis could be made only with histological examination, and surgery is the mainstay of treatment. Materials and methods: Here we present the case of a patient affected by a malignant Brenner tumor of the ovary, with metastases to brain, lung and liver and by a concomitant low grade endometroid adenocarcinoma of the uterus. A postoperative platinum based chemotherapy (CHT) was planned. The adjuvant treatment was discontinued for hematologic and liver toxicity and the patient died one month later due to a cardiorespiratory arrest. Results and discussion: For what concerns adjuvant therapy, it is supposed that chemotherapy is profitable in the survival of these patients, but what agents would really provide an objective response in the presence of metastatic disease is not standardized. Conclusion: Because of the rarity and the limited good quality research reports, multicentric prospective trials are needed to improve preoperative diagnosis of MBTs and investigate the best treatment.

KW - Brenner tumor

KW - Metastases

KW - Ovarian cancer

KW - Ovarian neoplasms

UR - http://www.scopus.com/inward/record.url?scp=85002246046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002246046&partnerID=8YFLogxK

U2 - 10.11138/giog/2016.38.4.339

DO - 10.11138/giog/2016.38.4.339

M3 - Review article

AN - SCOPUS:85002246046

VL - 38

SP - 339

EP - 344

JO - Giornale Italiano di Ostetricia e Ginecologia

JF - Giornale Italiano di Ostetricia e Ginecologia

SN - 0391-9013

IS - 4

ER -